Current Concepts for the Biological Basis of Dental Implants: Foreign Body Equilibrium and Osseointegration Dynamics

Oral and Maxillofacial Surgery Clinics of North America

Volumn 27, Issue 2, 2015, Pages 175-183

  Trindade, Ricardo ^a   Albrektsson, Tomas ^a,b   Wennerberg, Ann ^a  

^a MALMÖ UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Foreign body reaction; Implants; Osseointegration

Indexed keywords

BIOMATERIAL; TOOTH IMPLANT;

ADSORPTION; BONE REGENERATION; FOREIGN BODY REACTION; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; SURFACE PROPERTY; TOOTH IMPLANT; TOOTH IMPLANTATION;

ADSORPTION; BIOCOMPATIBLE MATERIALS; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; FOREIGN-BODY REACTION; HUMANS; INFLAMMATION; OSSEOINTEGRATION; SURFACE PROPERTIES;

EID: 84929514939     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coms.2015.01.004     Document Type: Review

References (52)

1. Albrektsson T., Branemark P.I., Hansson H.A., et al. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981, 52(2):155-170.
2. Lin Y., Huang P., Lu X., et al. The relationship between IL-1 gene polymorphism and marginal bone boss around dental implants. JOral Maxillofac Surg 2007, 65(11):2340-2344.
3. Shimpuku H., Nosaka Y., Kawamura T., et al. Genetic polymorphisms of the interleukin-1 gene and early marginal bone loss around endosseous dental implants. Clin Oral Implants Res 2003, 14(4):423-429.
4. Tang L., Hu W. Molecular determinants of biocompatibility. Expert Rev Med Devices 2005, 2(4):493-500.
5. Albrektsson T., Dahlin C., Jemt T., et al. Is marginal bone loss around oral implants the result of a provoked foreign body reaction?. Clin Implant Dent Relat Res 2014, 16(2):155-165.
6. Trindade R., Albrektsson T., Tengvall P., et al. Foreign body reaction to biomaterials: on mechanisms for build-up and breakdown of osseointegration. Clin Implant Dent Relat Res 2014, [Epub ahead of print].
7. Zhao E., Xu H., Wang L., et al. Bone marrow and the control of immunity. Cell Mol Immunol 2012, 9:11-19.
8. Fukumoto S., Martin T.J. Bone as an endocrine organ. Trends Endocrinol Metab 2009, 20(5):230-236.
9. Kular J., Tickner J., Chim S.M., et al. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem 2012, 45(12):863-873.
10. Frost H.M. Abrief review for orthopedic surgeons: fatigue damage (microdamage) in bone (its determinants and clinical implications). JOrthop Sci 1998, 3(5):272-281.
11. Du Z., Ivanovski S., Hamlet S.M., et al. The ultrastructural relationship between osteocytes and dental implants following osseointegration. Clin Implant Dent Relat Res 2014, 10.1111/cid.12257.
12. Chen Z., Wu C., Gu W., et al. Osteogenic differentiation of bone marrow MSCs by β-tricalcium phosphate stimulating macrophages via BMP2 signalling pathway. Biomaterials 2014, 35(5):1507-1518.
13. Roach P., Eglin D., Rohde K., et al. Modern biomaterials: a review - bulk properties and implications of surface modifications. JMater Sci Mater Med 2007, 18(7):1263-1277.
14. Bryers J.D., Giachelli C.M., Ratner B.D. Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts. Biotechnol Bioeng 2012, 109(8):1898-1911.
15. Hu W.J., Eaton J.W., Ugarova T.P., et al. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001, 98(4):1231-1238.
16. Rivera-Chacon D.M., Alvarado-Velez M., Acevedo-Morantes C.Y., et al. Fibronectin and vitronectin promote human fetal osteoblast cell attachment and proliferation on nanoporous titanium surfaces. JBiomed Nanotechnol 2013, 9(6):1092-1097.
17. Wennerberg A., Albrektsson T. Effects of titanium surface topography on bone integration: a systematic review. Clin Oral Implants Res 2009, 20(4):172-184.
18. Mozumder M.S., Zhu J., Perinpanayagam H. Titania-polymeric powder coatings with nano-topography support enhanced human mesenchymal cell responses. JBiomed Mater Res A 2012, 100(10):2695-2709.
19. Boyd A.R., Burke G.A., Duffy H., et al. Sputter deposited bioceramic coatings: surface characterisation and initial protein adsorption studies using surface-MALDI-MS. JMater Sci Mater Med 2011, 22(1):71-84.
20. Buchanan L.A., El-Ghannam A. Effect of bioactive glass crystallization on the conformation and bioactivity of adsorbed proteins. JBiomed Mater Res A 2010, 93(2):537-546.
21. Divya Rani V.V., Manzoor K., Menon D., et al. The design of novel nanostructures on titanium by solution chemistry for an improved osteoblast response. Nanotechnology 2009, 20(19):195101.
22. Khoo X., Hamilton P., O'Toole G.A., et al. Directed assembly of PEGylated-peptide coatings for infection-resistant titanium metal. JAm Chem Soc 2009, 131(31):10992-10997.
23. Jimbo R., Sawase T., Shibata Y., et al. Enhanced osseointegration by the chemotactic activity of plasma fibronectin for cellular fibronectin positive cells. Biomaterials 2007, 28(24):3469-3477.
24. Tang L., Eaton J.W. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. JExp Med 1993, 178(6):2147-2156.
25. Bougas K. On the influence of biochemical coating on implant bone incorporation 2012, [PhD Thesis], Department of Prosthodontics, Faculty of Odontology, Malmö University, Sweden.
26. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
27. Jones K.S. Effects of biomaterial-induced inflammation on fibrosis and rejection. Semin Immunol 2008, 20(2):130-136.
28. Ekdahl K.N., Lambris J.D., Elwing H., et al. Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev 2011, 63(12):1042-1050.
29. Nilsson B., Korsgren O., Lambris J.D., et al. Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?. Trends Immunol 2010, 31(1):32-38.
30. Smith M.J., White K.L., Smith D.C., et al. Invitro evaluations of innate and acquired immune responses to electrospun polydioxanone-elastin blends. Biomaterials 2009, 30(2):149-159.
31. Nilsson B., Ekdahl K.N., Mollnes T.E., et al. The role of complement in biomaterial-induced inflammation. Mol Immunol 2007, 44(1-3):82-94.
32. Arvidsson S., Askendal A., Tengvall P. Blood plasma contact activation on silicon, titanium and aluminium. Biomaterials 2007, 28(7):1346-1354.
33. Murray P.J., Wynn T.A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11(11):723-737.
34. Moreno J.L., Mikhailenko I., Tondravi M.M., et al. IL-4 promotes the formation of multinucleated giant cells from macrophage precursors by a STAT6-dependent, homotypic mechanism: contribution of E-cadherin. JLeukoc Biol 2007, 82(6):1542-1553.
35. Khan U.A., Hashimi S.M., Khan S., et al. Differential expression of chemokines, chemokine receptors and proteinases by foreign body giant cells (FBGCs) and osteoclasts. JCell Biochem 2014, 115:1290-1298.
36. Donath K., Donath K., Laass M., et al. The histopathology of different foreign-body reactions in oral soft tissue and bone tissue. Virchows Arch A Pathol Anat Histopathol 1992, 420(2):131-137.
37. Yagi M., Miyamoto T., Sawatani Y., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. JExp Med 2005, 202(3):345-351.
38. Tamaki Y., Sasaki K., Sasaki A., et al. Enhanced osteolytic potential of monocytes/macrophages derived from bone marrow after particle stimulation. JBiomed Mater Res B Appl Biomater 2008, 84(1):191-204.
39. Albrektsson T., Isidor F. Consensus report of session IV. Proceedings of the First European Workshop on Periodontology 1994, 365-369. Quintessence, London. N.P. Lang, T. Karring (Eds.).
40. Haynes D.R., Crotti T.N., Loric M., et al. Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritis joint. Rheumatology 2001, 40(6):623-630.
41. Crotti T.N., Smith M.D., Findlay D.M., et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFκB, RANK ligand and osteoprotegerin. Biomaterials 2004, 25(4):565-573.
42. Chrcanovic B.R., Albrektsson T., Wennerberg A. Reasons for failures of oral implants. JOral Rehabil 2014, 41(6):443-476.
43. Ujiie Y., Todescan R., Davies J.E. Peri-implant crestal bone loss: a putative mechanism. Int J Dent 2012, 2012:742439.
44. Higgins D.M., Basaraba R.J., Hohnbaum A.C., et al. Localized immunosuppressive environment in the foreign body response to implanted biomaterials. Am J Pathol 2009, 175(1):161-170.
45. Barrett A.W., Cruchley A.T., Williams D.M. Oral mucosal Langerhans' cells. Crit Rev Oral Biol Med 1996, 7(1):36-58.
46. Cutler C.W., Jotwani R. Dendritic cells at the oral mucosal interface. JDent Res 2006, 85(8):678-689.
47. Zaba L.C., Fuentes-Duculan J., Eungdamrong N.J., et al. Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis. JAllergy Clin Immunol 2010, 125(6):1261-1268.
48. Babensee J.E. Interaction of dendritic cells with biomaterials. Semin Immunol 2008, 20(2):101-108.
49. Hasséus B., Jontell M., Bergenholtz G., et al. Langerhans cells from human oral epithelium are more effective at stimulating allogeneic T cells invitro than Langerhans cells from skin. Clin Exp Immunol 2004, 136(3):483-489.
50. Hasséus B., Jontell M., Bergenholtz G., et al. T-cell costimulatory capacity of oral and skin epithelial cells invitro: presence of suppressive activity in supernatants from skin epithelial cell cultures. Eur J Oral Sci 2004, 112(1):48-54.
51. Mazlyzam A.L., Aminuddin B.S., Fuzina N.H., et al. Mazlyzam reconstruction of living bilayer human skin equivalent utilizing human fibrin as a scaffold. Burns 2007, 33(3):355-363.
52. Wang T.W., Sun J.S., Huang Y.C., et al. Skin basement membrane and extracellular matrix proteins characterization and quantification by real time RT-PCR. Biomaterials 2006, 27(29):5059-5068.